These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7923299)

  • 1. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
    Chujo M; Mori H; Tanaka E; Nakazawa H; Okino H
    Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N; Yang T; Levy MN
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel.
    Mori H; Chujo M; Tanaka E; Yamakawa A; Shinozaki Y; Mohamed MU; Nakazawa H
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1077-85. PubMed ID: 7900861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
    Warner MR; Senanayake PD; Ferrario CM; Levy MN
    Circ Res; 1991 Aug; 69(2):455-65. PubMed ID: 1776971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T; Iwai T; Haruta K; Takeda K
    Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and control of vascular resistance in skeletal muscle.
    Revington M; McCloskey DI
    Regul Pept; 1988 Dec; 23(3):331-42. PubMed ID: 3238054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
    Goodson AR; Leibold JM; Gutterman DD
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
    Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.